Why This Matters for Your Career
GE HealthCare is hiring 1 role related to this product
Company
GE HealthCare
IODIXANOL (iodixanol) by GE HealthCare is x-ray contrast activity [moa]. Approved for radiographic contrast agent [epc]. First approved in 2022.
Drug data last refreshed 18h ago
X-Ray Contrast Activity
Radiographic Contrast Agent
Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography
Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
Worked on IODIXANOL at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
GE HealthCare is hiring 1 role related to this product